MX362686B - Inmunógenos fúngicos y materiales y métodos relacionados. - Google Patents

Inmunógenos fúngicos y materiales y métodos relacionados.

Info

Publication number
MX362686B
MX362686B MX2015012381A MX2015012381A MX362686B MX 362686 B MX362686 B MX 362686B MX 2015012381 A MX2015012381 A MX 2015012381A MX 2015012381 A MX2015012381 A MX 2015012381A MX 362686 B MX362686 B MX 362686B
Authority
MX
Mexico
Prior art keywords
methods
related materials
valley fever
fungal immunogens
fungal
Prior art date
Application number
MX2015012381A
Other languages
English (en)
Other versions
MX2015012381A (es
Inventor
J Orbach Marc
F Shubitz Lisa
P Narra Hema
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Publication of MX2015012381A publication Critical patent/MX2015012381A/es
Publication of MX362686B publication Critical patent/MX362686B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente descripción proporciona materiales inmunogénicos y los métodos útiles para reducir el riesgo de infecciones por hongos, en particular fiebre amarilla. La descripción también proporciona análisis para identificar compuestos útiles para tratar la fiebre amarilla, así como los métodos para mejorar los síntomas de la fiebre amarilla.
MX2015012381A 2013-03-11 2014-03-11 Inmunógenos fúngicos y materiales y métodos relacionados. MX362686B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361776770P 2013-03-11 2013-03-11
US201361777845P 2013-03-12 2013-03-12
PCT/US2014/023606 WO2014164843A1 (en) 2013-03-11 2014-03-11 Fungal immunogens and related materials and methods

Publications (2)

Publication Number Publication Date
MX2015012381A MX2015012381A (es) 2017-03-10
MX362686B true MX362686B (es) 2019-02-01

Family

ID=51658990

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015012381A MX362686B (es) 2013-03-11 2014-03-11 Inmunógenos fúngicos y materiales y métodos relacionados.

Country Status (3)

Country Link
US (4) US9884097B2 (es)
MX (1) MX362686B (es)
WO (1) WO2014164843A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014164843A1 (en) * 2013-03-11 2014-10-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona, A Body Corporate Duly Formed In Fungal immunogens and related materials and methods
WO2023168416A1 (en) * 2022-03-04 2023-09-07 Anivive Lifesciences, Inc. Spore-based vaccine formulations and methods for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6923973B1 (en) * 2001-02-22 2005-08-02 Board Of Regents, The University Of Texas System Peptide and DNA immunization against Coccidioides immitis infections
US20040076981A1 (en) * 2001-11-21 2004-04-22 Olen Yoder Fungal gene cluster associated with pathogenesis
WO2005071091A1 (fr) * 2003-12-23 2005-08-04 Bayer Cropscience Sa Methode pour modifier l'expression genique d'un champignon phytopathogene
WO2006065549A2 (en) * 2004-12-03 2006-06-22 Medical University Of Ohio Attenuated vaccine useful for immunizations against coccidioides spp. infections
WO2014164843A1 (en) * 2013-03-11 2014-10-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona, A Body Corporate Duly Formed In Fungal immunogens and related materials and methods

Also Published As

Publication number Publication date
US20200155657A1 (en) 2020-05-21
US10413602B2 (en) 2019-09-17
US20160067320A1 (en) 2016-03-10
US9884097B2 (en) 2018-02-06
US20200297826A9 (en) 2020-09-24
US10758600B2 (en) 2020-09-01
US20210046169A1 (en) 2021-02-18
MX2015012381A (es) 2017-03-10
US11260092B2 (en) 2022-03-01
WO2014164843A1 (en) 2014-10-09
US20180117132A1 (en) 2018-05-03

Similar Documents

Publication Publication Date Title
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
EA201690280A1 (ru) Композиции и способы, относящиеся к выделенным эндофитам
MX2016002571A (es) Regulador de ph de transduccion.
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
TWD162495S (zh) 垃圾筒
MY189912A (en) Substituted xanthines and methods of use thereof
HK1223923A1 (zh) 用於治療癌症的作為 突變體抑制劑的 -或 -二氨基嘧啶化合物
MX2016005760A (es) Inhibidores de glucogeno sintasa cinasa 3 (gsk-3).
EA201591712A1 (ru) Антибиотические композиции на основе цефтолозана
MX2016003823A (es) Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma.
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
PH12015502665A1 (en) Improvements in or relating to organic compounds
EA201690036A1 (ru) Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
TWD167038S (zh) 瓶子
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
NZ631639A (en) Methods and compositions for treating and diagnosing acute myocardial infarction
MY174711A (en) Novel anti-fc-gamma receptor iib antibodies and uses thereof
TWD193548S (zh) 汽車
MX2015016766A (es) Nuevos derivados de tetrazolona.
IN2013MU01113A (es)
MX362686B (es) Inmunógenos fúngicos y materiales y métodos relacionados.

Legal Events

Date Code Title Description
FG Grant or registration